Meno Essence
Natural health product licensed in Canada
- Licence holder
- Grand Health Inc
- NPN or DIN-HM
- 80056279
- Status
- Active licence
- Licence date
- 5 December 2014
- Revision date
- 15 August 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 30 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 30 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Angelica sinensis Source : Angelica sinensis - Racine Extraction ratio : 1:1 Dry plant equivalent : 50 milligramme | 50 milligramme | Not calculated |
| Vitamine D | 2.5 microgrammes | Not calculated |
| Zingiber officinale Source : Zingiber officinale - Rhizome Extraction ratio : 1:1 Dry plant equivalent : 25 milligramme | 25 milligramme | Not calculated |
| Actaea racemosa Source : Actaea racemosa - Rhizome Extraction ratio : 1:1 Dry plant equivalent : 40 milligramme Potency : 2.5 % Triterpene glycoside | 40 milligramme | Not calculated |
| Actaea racemosa Source : Actaea racemosa - racine Extraction ratio : 1:1 Dry plant equivalent : 40 milligramme Potency : 2.5 % Triterpene glycoside | 40 milligramme | Not calculated |
| Vitex agnus-castus Source : Vitex agnus-castus - Fruit Potency : 0.5 % Agnuside | Not specified | Not calculated |
| Vitex agnus-castus Source : Vitex agnus-castus - Fruit Extraction ratio : 1:1 Dry plant equivalent : 50 milligramme Potency : 5 % Vitexin | 50 milligramme | Not calculated |
| Calcium | 140 milligramme | 280,000 µg |
| Magnésium | 100 milligramme | 200,000 µg |
| Vitamine B6 | 15 milligramme | 30,000 µg |
Non-medicinal ingredients
farine de riz, Stéarate de magnésium, Maltodextrine, Eau purifiée, Microcrystalline cellulose, Dioxyde de silicium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 1 day ; maximum: 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Adequate calcium and vitamin D throughout life as part of a healthy diet, along with physical activity may reduce the risk of developing osteoporosis in peri-and postmenopausal women. Helps relieve symptoms associated with menopause. Traditionally used in Herbal Medicine to help ease nervous tension. Used in Herbal Medicine to help relieve symptoms associated with menopause, such as hot flashes.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80056279
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging